Keyphrases
Voriconazole
100%
Human Osteoblasts
100%
Fluoride
100%
Osteogenic Activity
100%
Vascular Endothelial Growth Factor
30%
Osteoblast
30%
Platelet-derived Growth factor-BB (PDGF-BB)
30%
Periostitis
30%
Fluconazole
30%
Osteogenic Differentiation
20%
Gene Expression
10%
Supernatant
10%
Enzyme-linked Immunosorbent Assay (ELISA)
10%
Cell Proliferation
10%
Systemic Administration
10%
Clinical Application
10%
Clinical Symptoms
10%
Osteogenesis
10%
Cellular DNA
10%
In Vitro Activity
10%
Clinical Observation
10%
Local Administration
10%
Alkaline Phosphatase Activity
10%
Ion-selective Electrode
10%
Biological Mechanisms
10%
Fluoride Level
10%
Osteogenic
10%
Non-carcinogenic
10%
Therapy Discontinuation
10%
Triazole
10%
Calcium Accumulation
10%
Osteoblast Proliferation
10%
Osteoblastic Activity
10%
Periarticular Ossification
10%
Biochemistry, Genetics and Molecular Biology
Osteoblast
100%
Vascular Endothelial Growth Factor
50%
Platelet-Derived Growth Factor
50%
Bone Development
33%
Cell Proliferation
16%
Enzyme
16%
Cytokine
16%
Alkaline Phosphatase
16%
Supernatant
16%
Ossification
16%
Immunology and Microbiology
Osteoblast
100%
Vasculotropin
50%
Platelet Derived Growth Factor
50%
Bone Development
33%
Cytokine
16%
Cell Proliferation
16%
Enzyme-Linked Immunosorbent Assay
16%
Supernatant
16%
Ossification
16%
Pharmacology, Toxicology and Pharmaceutical Science
Voriconazole
100%
Vasculotropin
30%
Platelet Derived Growth Factor
30%
Fluconazole
30%
Periostitis
30%
Enzyme-Linked Immunosorbent Assay
10%
Cytokine
10%
Cell DNA
10%
Alkaline Phosphatase
10%
Triazole Derivative
10%